Lenvatinib and Pleural effusion - a phase IV clinical study of FDA data

Summary:

Pleural effusion is reported as a side effect among people who take Lenvatinib (lenvatinib), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Levothyroxine Sodium, and have Renal cell carcinoma.

The phase IV clinical study analyzes which people have Pleural effusion when taking Lenvatinib. It is created by eHealthMe based on reports of 3,586 people who have side effects when taking Lenvatinib from the FDA, and is updated regularly.

What is Lenvatinib?

Lenvatinib has active ingredients of lenvatinib. eHealthMe is studying from 3,587 Lenvatinib users. Check the latest studies of Lenvatinib.

What is Pleural effusion?

Pleural effusion (water on the lungs) is found to be associated with 2,221 drugs and 3,149 conditions by eHealthMe. Check the latest studies of Pleural effusion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

3,586 people reported to have side effects when taking Lenvatinib.
Among them, 20 people (0.56%) have Pleural effusion.

Could Lenvatinib cause Pleural effusion?

Among these 20 people:

How long have people been on Lenvatinib when they have Pleural effusion? *

What is the gender of people who have Pleural effusion when taking Lenvatinib? *

female: 30 %
male: 70 %

What is the age of people who have Pleural effusion when taking Lenvatinib? *

What are other drugs people take besides Lenvatinib? *

What are other side effects people have besides Pleural effusion? *

Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 10.00%
Atypical Mycobacterial Infection (infections caused by several types of mycobacterium similar to the germ that causes tuberculosis): 2 people, 10.00%
Dyspnea (difficult or laboured breathing): 2 people, 10.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 10.00%
Ascites (accumulation of fluid in the abdominal cavity): 1 person, 5.00%
Chills (felling of cold): 1 person, 5.00%
Diarrhea: 1 person, 5.00%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 1 person, 5.00%
Anaemia (lack of blood): 1 person, 5.00%
Uterine Perforation (accidental puncture of the uterus): 1 person, 5.00%

What are the existing conditions these people have? *

Renal Cell Carcinoma (a kidney cancer): 6 people, 30.00%
Hepatocellular Carcinoma (liver cancer): 3 people, 15.00%
Thyroid Cancer: 2 people, 10.00%
Endometrial Cancer: 2 people, 10.00%
Tumor Thrombosis: 1 person, 5.00%
Papillary Thyroid Cancer: 1 person, 5.00%
Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 1 person, 5.00%
Metastases To Central Nervous System (cancer spreads to central nervous system): 1 person, 5.00%
Hyperthyroidism (over activity of the thyroid gland): 1 person, 5.00%
Endometrial Cancer Recurrent: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Lenvatinib and have Pleural effusion?

- Check whether Pleural effusion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lenvatinib:

Lenvatinib (3,587 reports)

Pleural effusion treatments and more:

Pleural effusion (84,634 reports)

Browse all side effects of Lenvatinib:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pleural effusion:

Pleural effusion (2,221 drugs)

Browse all the conditions that are associated with Pleural effusion:

Pleural effusion (3,149 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lenvatinib (the active ingredients of Lenvatinib) and Lenvatinib (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.